1189 ONCE-DAILY NS5A INHIBITOR (BMS-790052) PLUS PEGINTERFERON-ALPHA-2A AND RIBAVIRIN PRODUCES HIGH RATES OF EXTENDED RAPID VIROLOGIC RESPONSE IN TREATMENT-NAIVE HCV-GENOTYPE 1 SUBJECTS: PHASE 2A TRIAL

✍ Scribed by Pol, S.; Everson, G.; Ghalib, R.; Rustgi, V.; Martorell, C.; Tatum, H.A.; Lim, J.; Hezode, C.; Diva, U.; Yin, P.D.; Hindes, R.

• Book ID: 121892339
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 52 KB
• Volume: 52
• Category: Article
• ISSN: 0168-8278
• DOI: 10.1016/S0168-8278(10)61190-7